Effects of vitamin D on ovary in DHEA-treated PCOS rat model: A light and electron microscopic study

References

• Dunaif A. Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis. Endocr Rev. 1997;18(6):774–800.
   PubMed Web of Science ®Google Scholar
• S M S, Pate KA. Epidemiology, diagnosis, and management of polycystic ovary syndrome. Clin Epidemiol. 2014;6:1–13.
   Web of Science ®Google Scholar
• Talbott EO, Zborowskii JV, Boudraux MY. Do women with polycystic ovary syndrome have an increased risk of cardiovascular disease? Review of the evidence. Minerva Ginecol. 2004;56(1):27–39.
   PubMedGoogle Scholar
• C J A, E P T, Lepor NE. Polycystic ovary syndrome: A major unrecognized cardiovascular risk factor in women. Rev Cardiovasc Med. 2009;10(2):83–90.
   PubMed Web of Science ®Google Scholar
• Wehr E, Pilz S, Schweighofer N, et al. Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome. Eur J Endocrinol. 2009;161:575–580.
   PubMed Web of Science ®Google Scholar
• Y H M K-P, Snacke C, Louwers Y, et al. The role of vitamin D in metabolic disturbances in polycystic ovary syndrome: A systematic review. Eur J Endocrinol. 2013;169:853–865.
   PubMed Web of Science ®Google Scholar
• Panidis D, Balaris C, Farmakiotis D, et al. Serum parathyroid hormone concentrations are increased in women with polycystic ovary syndrome. Clin Chem. 2005;51:9.
   PubMed Web of Science ®Google Scholar
• S K P, Nasrat H, Goswami B, Vitamin JA. D as a predictor of insulin resistance in polycystic ovarian syndrome. Diabetes Metab Syndrome: Clin Res Rev. 2012;6:146–149.
   PubMedGoogle Scholar
• R L T, Spedding S, Buckley JD. Vitamin D in the aetiology and management of polycystic ovary syndrome. Clin Endocrinol (Oxf). 2012;77:343–350.
   PubMed Web of Science ®Google Scholar
• Anagnostis P, Karras S, Goulis DG. Vitamin D in human reproduction: A narrative review. Int J Clin Pract. 2012;77(3):343–350.
   Google Scholar
• Lerchbaum E, Pietsch BO. Vitamin D and fertility: A systematic review. Eur J Endocrinol. 2012;166:765–778.
   PubMed Web of Science ®Google Scholar
• Masszi G, Novak A, Tarszabo R, et al. Effects of vitamin D3 derivative –calcitriol on pharmacological reactivity of aortic rings in a rodent PCOS model. Pharmacol Rep. 2013;65:476–483.
   PubMed Web of Science ®Google Scholar
• Sára L, Nádasy G, Antal P, et al. Arteriolar biomechanics in a rat polycystic ovary syndrome model – Effects of parallel vitamin D3 treatment. Acta Physiol Hung. 2012;99(3):279–288.
   PubMedGoogle Scholar
• K A W, C M A, Handelsman DJ. Rodent models for human polycystic ovary syndrome. Biol Reprod. 2012;86(5):149.
   PubMed Web of Science ®Google Scholar
• Mesbah F, Mohsen M, Zahra V, Mirkhani H. Does metformin improve in vitro maturation and ultrastructure of oocytes retrieved from estradiol valerate polycystic ovary syndrome-induced rats. J Ovarian Res. 2015;8:74.
   PubMed Web of Science ®Google Scholar
• Jang M, M J L, J M L, et al. Oriental medicine Kyung-Ok-Ko prevents and alleviates dehydroepiandrosterone-induced polycystic ovarian syndrome in rats. PLoS ONE. 2014;9(2):e87623.
   PubMed Web of Science ®Google Scholar
• Sander V, Luchetti CG, Solano ME, et al. Role of the N, N’-dimethylbiguanide metformin in the treatment of female prepuberal BALB/c mice hyperandrogenized with dehydroepiandrosterone. Reproduction. 2006;131(3):591–602.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang C, Shen S, et al. Dehydroepiandrosterone induces ovarian and uterine hyperfibrosis in female rats. Hum Reprod. 2013;3074–3085. DOI:10.1093/humrep/det341
   PubMed Web of Science ®Google Scholar
• Lai H, Jia X, Yu Q, et al. High-fat diet induces significant metabolic disorders in a mouse model of polycystic ovary syndrome. Biol Reprod. 2014;91(5):127.
   PubMed Web of Science ®Google Scholar
• Wang F, Zhang Z, Wang Z, et al. Expression and clinical significance of the HIF-1a/ET-2 signaling pathway during the development and treatment of polycystic ovary syndrome. J Mol Histol. 2015;46(2):173–181.
   PubMed Web of Science ®Google Scholar
• Tessaro I, S C M, Franciosi F, et al. Effect of oral administration of low-dose follicle stimulating hormone on hyperandrogenized mice as a model of polycystic ovary syndrome. J Ovarian Res. 2015;8:64.
   PubMed Web of Science ®Google Scholar
• Sun X, Wu X, Zhou Y, Yu X, Zhang W. Evaluation of apelin and insulin resistance in patients with PCOS and therapeutic effect of drospirenone-ethinylestradiol plus Metformin/Xianchang Sun. Med Sci Monit Int Med J Exp Clin Res. 2015;28(21):2547–2552.
   Google Scholar
• C G L, M E S, Sander V, et al. Effects of dehydroepiandrosterone on ovarian cystogenesis and immune function. J Reprod Immunol. 2004;64(1–2):59–74.
   PubMed Web of Science ®Google Scholar
• C J G, Magre S. Contribution of germ cells to the differentiation and maturation of the ovary: Insights from models of germ cell depletion. Biol Reprod. 2006;74:450–458.
   PubMed Web of Science ®Google Scholar
• Azzolin GC, Saiduddin S. Effect of androgens on the ovarian morphology of the hypophysectomized rat. Proc Soc Exp Biol Med. 1983;172(1):70–73.
   PubMed Web of Science ®Google Scholar
• Billig H, Furuta I, Hsueh AJ. Estrogens inhibit and androgens enhance ovarian granulosa cell apoptosis. Endocrinology. 1993;133(5):2204–2212.
   PubMed Web of Science ®Google Scholar
• Lee CT, Wang JY, Chou KY, Hsu MI. 1,25-Dihydroxyvitamin D3 increases testosterone-induced 17beta-estradiol secretion and reverses testosterone-reduced connexin 43 in rat granulosa cells. Reprod Biol Endocrinol. 2014;12:90.
   PubMed Web of Science ®Google Scholar
• Kodaman PH. Statins: do they have potential in the treatment of polycystic ovary syndrome? Semin Reprod Med. 2008;26(1):127–138.
   PubMed Web of Science ®Google Scholar
• Okutsu Y, Itoh MT, Takahashi N, Ishizuka B. Exogenous androstenedione induces formation of follicular cysts and premature luteinization of granulosa cells in the ovary. Fertil Steril. 2010;93(3):927–935.
   PubMed Web of Science ®Google Scholar
• Luo W, Wiltbank MC. Distinct regulation by steroids of messenger RNAs for FSHR and CYP19A1 in bovine granulosa cells. Biol Reprod. 2006;75(2):217–225.
   PubMed Web of Science ®Google Scholar
• Hamel M, Vanselow J, Nicola ES, Price CA. Androstenedione increases cytochrome P450 aromatase messenger ribonucleic acid transcripts in nonluteinizing bovine granulosa cells. Mol Reprod Dev. 2005;70(2):175–183.
   PubMed Web of Science ®Google Scholar
• Wu YG, Bennett J, Talla D, Testosterone SC. not 5α-dihydrotestosterone, stimulates LRH-1 leading to FSH-independent expression of Cyp19 and P450scc in granulosa cells. Mol Endocrinol. 2011;25(4):656–668.
   PubMed Web of Science ®Google Scholar